The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections.
Matt DriedgerNick DanemanKevin A BrownWayne L GoldSarah C J JorgensenColleen MaxwellKevin L SchwartzAndrew M MorrisDeva ThiruchelvamBradley LangfordElizabeth LeungDerek MacFaddenPublished in: Microbiology spectrum (2023)
Bacterial infections are a significant cause of morbidity and mortality worldwide. In the wake of the COVID-19 pandemic, previous studies have demonstrated pandemic-related shifts in the epidemiology of bacterial bloodstream infections (BSIs) in the general population and in specific hospital systems. Our study uses a large, comprehensive data set stratified by setting [community, long-term care (LTC), and hospital] to uniquely demonstrate how the effect of the COVID-19 pandemic on BSIs and testing practices varies by healthcare setting. We showed that, while the number of false-positive blood culture results generally increased during the pandemic, this effect did not apply to hospitalized patients. We also found that many infections were likely under-recognized in patients in the community and in LTC, demonstrating the importance of maintaining healthcare for these groups during crises. Last, we found a decrease in infections caused by certain pathogens in the community, suggesting some secondary benefits of pandemic-related public health measures.
Keyphrases
- healthcare
- coronavirus disease
- sars cov
- public health
- long term care
- end stage renal disease
- newly diagnosed
- mental health
- ejection fraction
- primary care
- prognostic factors
- health information
- emergency department
- electronic health record
- peritoneal dialysis
- big data
- risk factors
- machine learning
- adverse drug
- case control
- artificial intelligence
- social media
- multidrug resistant